Sudarshan Pharma Industries Share Price
27 Oct, 2026 4:01 PM (IST)
Sudarshan Pharma Industries Performance
- Today's Low
- ₹32
- Today's High
- ₹35
- 52 Week Low
- ₹19
- 52 Week High
- ₹43
- Open Price₹33
- Previous Close₹32
- Volume139,029
- 50 DMA₹37.00
- 100 DMA₹36.40
- 200 DMA₹34.20
Sudarshan Pharma Industries Chart
Investment Returns
- Over 1 Month -9.14%
- Over 3 Month -16.36%
- Over 6 Month + 15.48%
- Over 1 Year + 45.39%
Smart Investing Starts Here Start SIP with Sudarshan Pharma Industries for Steady Growth!
Sudarshan Pharma Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 36.1
- PEG Ratio
- 2.2
- Market Cap Cr
- 842
- P/B Ratio
- 5.2
- Average True Range
- 2
- EPS
- 1
- Dividend Yield
- 0
- MACD Signal
- -1.6
- RSI
- 32.51
- MFI
- 20.32
Latest Stock News Updates
Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve i) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30-Sep-2026; ii) consider and approve proposal for raising of funds and other ancillary functions, subject to such statutory and regulatory approvals as may be necessary.
- BSE India
- 22 hours 49 minutes ago
We are pleased to inform you that the Company ahs received letter from National Stock Exchange of India Limited dated 23-Oct-2026 stating that the equity shares of the Company shall be listed and admitted to dealings on the Exchange (Capital Market segment) w.e.f. 27-Oct-2026 pursuant to migration from SME platform of BSE Limited.
- BSE India
- 3 days 23 hours ago
In continuation of the Company''s letters dated 05/Sep/2026 and 15/Sep/2026, this is to inform you that the proposal to acquire 9.50% equity shares of common stock of Med Therapy Biotechnology Inc., USA stands terminated. The proposal to acquire 1.50% each of the equity shares of common stock of Med Therapy by Mr. Hemal Mehta and Mr. Sachin Mehta, Promoters of the Company also stands terminated.
- BSE India
- 2 weeks 6 days ago
Sudarshan Pharma Industries Financials
Sudarshan Pharma Industries Technicals
EMA & SMA
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹35.80
- 50 Day
- ₹37.00
- 100 Day
- ₹36.40
- 200 Day
- ₹34.20
Resistance and Support
- R3 38.10
- R2 35.70
- R1 33.80
- S1 29.60
- S2 27.20
- S3 25.30
Sudarshan Pharma Industries Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-10-29 | Half Yearly Results & issue of Warrants | |
| 2026-08-12 | Quarterly Results | |
| 2026-06-18 | Issue Of Warrants | Inter-alia, to consider 1. Proposal for raising of funds by way of issue of one or more instruments through private placement / preferential issue or such method or combination thereof |
| 2026-05-21 | Others | (Revised) Inter-alia to consider 1. Approve Migration of listing / trading of the Equity Shares. 2. Approve Postal Ballot Notice & Calendat of events for seekirg approval. 3. Other business matters. |
| 2026-05-15 | Others | Inter-alia, to consider 1. The proposal for the issuance of Foreign Currency Convertible Bonds, subject to receipt of applicable regulatory and statutory approvals. |
About Sudarshan Pharma Industries
Sudarshan Pharma Industries engaged in manufacturing having plant for API and doing jobwork manufacturing in Pharmeceutical Items and traders in Chemicals and Solvents in India. View More- NSE Symbol
- SUDARSHAN
- BSE Symbol
- 543828
- ISIN
- INE00TV01023
Similar Stocks to Sudarshan Pharma Industries
Popular Stocks
Sudarshan Pharma Industries FAQs
Sudarshan Pharma Industries share price is ₹34 As on 27 October, 2026 | 17:32
The Market Cap of Sudarshan Pharma Industries is ₹841.8 Cr As on 27 October, 2026 | 17:32
The P/E ratio of Sudarshan Pharma Industries is 36.1 As on 27 October, 2026 | 17:32
The PB ratio of Sudarshan Pharma Industries is 5.2 As on 27 October, 2026 | 17:32
The 52 week High & Low of Sudarshan Pharma Industries is ₹42.8/₹18.5 respectively As on 27 October, 2026 | 17:32
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.